AMACR and pachyonychia congenita: The diagnosis was determined by 1 pathologist (DT) on slides stained with antibodies targeting AMACR/p63/34BE12 to distinguish PC from benign glands [41] prior to RμS acquisitions on adjacent tissue sections (Fig 2A).